Journal Article
. 2015 Dec;15().
doi: 10.1186/s12907-015-0021-5.

Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients

Xi Wang 1 Brian Z Ring 2 Robert S Seitz 3 Douglas T Ross 4 Kirsten Woolf 1 Rodney A Beck 5 David G Hicks 1 Shuyuan Yeh 1 
  • PMID: 26664297
  •     23 References


Background: The role of vitamin E in breast cancer prevention and treatment has been widely investigated, and the different tocopherols that comprise this nutrient have been shown to have divergent associations with cancer outcome. Our previous studies have shown that α-Tocopherol-associated protein (TAP), a vitamin E binding protein, may function as a tumor suppressor-like factor in breast carcinogenesis. The current study addresses the association of TAP expression with breast cancer clinical outcomes.

Methods: Immunohistochemical stain for TAP was applied to a tissue microarray from a breast cancer cohort consisting of 271 patients with a median follow-up time of 5.2 years. The expression of TAP in tumor cells was compared with patient's clinical outcome at 5 years after diagnosis. The potential role of TAP in predicting outcome was also assessed in clinically relevant subsets of the cohort. In addition, we compared TAP expression and Oncotype DX scores in an independent breast cancer cohort consisting of 71 cases.

Results: We demonstrate that the expression of TAP was differentially expressed within the breast cancer cohort, and that ER+/PR ± tumors were more likely to exhibit TAP expression. TAP expression was associated with an overall lower recurrence rate and a better 5-year survival rate. This association was primarily in patients with ER+ tumors; exploratory analysis showed that this association was strongest in patients with node-positive tumors and was independent of stage and treatment with chemotherapy. TAP expression in ER/PR negative or triple negative tumors had no association with clinical outcome. In addition, we did not observe an association between TAP expression and Oncotype DX recurrence score.

Conclusions: The significant positive association we found for α-Tocopherol-associated protein with outcome in breast cancer may help to better define and explain studies addressing α-tocopherol's association with cancer risk and outcome. Additionally, further studies to validate and extend these findings may allow TAP to serve as a breast-specific prognostic marker in breast cancer patients, especially in those patients with ER+ tumors.

Keywords: Breast cancer; Vitamin E; α-Tocopherol-associated protein (TAP).

Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
Jing Ni, Xingqiao Wen, +10 authors, Shuyuan Yeh.
Cancer Res, 2005 Nov 04; 65(21). PMID: 16267002
Selective cancer cell killing by alpha-tocopheryl succinate.
J Neuzil, T Weber, N Gellert, C Weber.
Br J Cancer, 2001 Jan 05; 84(1). PMID: 11139318    Free PMC article.
Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
Kristen Anderson, Marla Simmons-Menchaca, +3 authors, Kimberly Kline.
Cancer Res, 2004 Jun 19; 64(12). PMID: 15205340
Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas.
Sharlin Johnykutty, Ping Tang, +3 authors, Xi Wang.
Mod Pathol, 2009 Mar 24; 22(6). PMID: 19305383
A consensus prognostic gene expression classifier for ER positive breast cancer.
Andrew E Teschendorff, Ali Naderi, +5 authors, Carlos Caldas.
Genome Biol, 2006 Nov 02; 7(10). PMID: 17076897    Free PMC article.
Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast cancer.
Xi Wang, Jing Ni, +5 authors, Shuyuang Yeh.
Cancer Invest, 2009 Nov 17; 27(10). PMID: 19909011
The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis.
Julie Stratton, Marshall Godwin.
Fam Pract, 2011 Jan 29; 28(3). PMID: 21273283
Systematic Review.
Alteration of α-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development.
Ka-Wai Tam, Chi-Tang Ho, +6 authors, Yuan-Soon Ho.
Food Chem, 2013 Feb 16; 138(2-3). PMID: 23411208
Vitamin E and breast cancer.
Kimberly Kline, Weiping Yu, Bob G Sanders.
J Nutr, 2004 Dec 01; 134(12 Suppl). PMID: 15570054
A gamma-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth.
Gang Lu, Hang Xiao, +6 authors, Chung S Yang.
Carcinogenesis, 2010 Jan 26; 31(4). PMID: 20097733    Free PMC article.
A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization.
S Zimmer, A Stocker, +3 authors, A Azzi.
J Biol Chem, 2000 Jun 01; 275(33). PMID: 10829015
Vitamin E succinate promotes breast cancer tumor dormancy.
M P Malafa, L T Neitzel.
J Surg Res, 2000 Aug 18; 93(1). PMID: 10945959
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.
Brian Z Ring, Robert S Seitz, +9 authors, Douglas T Ross.
J Clin Oncol, 2006 Jul 01; 24(19). PMID: 16809728
Cancer-preventive activities of tocopherols and tocotrienols.
Jihyeung Ju, Sonia C Picinich, +4 authors, Chung S Yang.
Carcinogenesis, 2009 Sep 15; 31(4). PMID: 19748925    Free PMC article.
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Eric A Klein, Ian M Thompson, +18 authors, Laurence H Baker.
JAMA, 2011 Oct 13; 306(14). PMID: 21990298    Free PMC article.
Highly Cited.
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
Yixin Wang, Jan G M Klijn, +11 authors, John A Foekens.
Lancet, 2005 Feb 22; 365(9460). PMID: 15721472
Highly Cited.
Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols.
W Yu, M Simmons-Menchaca, +2 authors, K Kline.
Nutr Cancer, 1999 May 05; 33(1). PMID: 10227040
The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.
A Hamilton, M Piccart.
Ann Oncol, 2000 Aug 15; 11(6). PMID: 10942052
A gene-expression signature as a predictor of survival in breast cancer.
Marc J van de Vijver, Yudong D He, +18 authors, René Bernards.
N Engl J Med, 2002 Dec 20; 347(25). PMID: 12490681
Highly Cited.
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
I-Min Lee, Nancy R Cook, +5 authors, Julie E Buring.
JAMA, 2005 Jul 07; 294(1). PMID: 15998891
Highly Cited.
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.
Fabien Reyal, Martin H van Vliet, +10 authors, Lodewyk F A Wessels.
Breast Cancer Res, 2008 Nov 19; 10(6). PMID: 19014521    Free PMC article.